GlaxoSmithKline (GSK)

Tweet this page
How to read and use this data card.

Lobbying costs:

WARNING: As this organisation lists one or more EP accredited lobbyists, it is highly improbable that its lobbying costs are lower than €10,000.

WARNING: The lobbying costs declared by this organisation are extraordinarily high and may therefore have been over-declared.

1,750,000€ - 1,999,999€

Financial year: 01/01/2019 - 01/12/2019

Lobbyists declared: 5.75 FTE (13)

WARNING: The number of full time equivalent lobbyists declared by this organisation are extraordinarily high and may therefore have been over-declared.


Lobbyists with EP accreditation: 0

Meetings with European Commission: 0

Lobbying costs over the years:


GlaxoSmithKline (GSK)

Registration on EU Transparency Register

7990322925-77 (First registered: 06 Jan 2009)

Goals / Remit

We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.

We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.

Our goal is to be one of the world’s most innovative, best performing and trusted healthcare companies.

Our values and expectations are at the heart of everything we do and help define our culture - so that together we can deliver extraordinary things for our patients and consumers and make GSK a brilliant place to work. Our values are Patient focus, Transparency, Respect, Integrity. Our expectations are Courage, Accountability, Development, Teamwork.

We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our three global businesses, scientific and technical know-how and talented people.

Our Pharmaceuticals business has a broad portfolio of innovative and established medicines with leadership positions in respiratory and HIV. Our R&D approach focuses on science related to the immune system, use of genetics and advanced technologies.

Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to help protect people throughout life. We deliver over two million vaccine doses per day to people living in over 160 countries.

Our Consumer Healthcare business develops and markets an innovative portfolio of consumer preferred and expert recommended brands in the Pain relief, Respiratory, Digestive health, Oral health, Nutrition and Skin health categories.
Our operations span the value chain from identifying, researching, developing and testing ground-breaking
discoveries, to regulatory approval, manufacturing and commercialisation.

We have over 99,000 employees across 95 countries with outstanding scientific and technical know-how and
deep expertise.


We follow EU initiatives, policies and legislative files related to our Pharmaceuticals, Vaccines and Consumer Healthcare businesses. This includes topics such as R&D and clinical trials, the EU Cancer Plan, health technology assessment, antimicrobial resistance, digital health, pharmaceutical legislation, medical devices, vaccines, trade, industrial strategy, IP, environment.


Head office:
Great West Road, 980
Brentford, Middlesex TW8 9GS
United Kingdom

Tel: 44 20 8047 5000

Belgium office:
37 Square de Meeûs
Brussels 1000,

Tel: 32 27917600